258 related articles for article (PubMed ID: 26315864)
1. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.
Amin A; El-Kareem MA; Yahia AB
Nucl Med Rev Cent East Eur; 2015; 18(2):61-4. PubMed ID: 26315864
[TBL] [Abstract][Full Text] [Related]
2. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
3. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
[TBL] [Abstract][Full Text] [Related]
5. Three phase bone scintigraphy with (99m)Tc-MDP and serological indices in detecting infection after internal fixation in malunion or nonunion traumatic fractures.
Yang F; Yang Z; Feng J; Zhang L; Ma D; Yang J
Hell J Nucl Med; 2016; 19(2):130-4. PubMed ID: 27331206
[TBL] [Abstract][Full Text] [Related]
6. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
7. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m MDP and indium-111 chloride scintigraphy in skeletal tuberculosis.
Nocera RM; Sayle B; Rogers C; Wilkey D
Clin Nucl Med; 1983 Sep; 8(9):418-20. PubMed ID: 6227442
[TBL] [Abstract][Full Text] [Related]
10. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
11. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
13. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
MacDonald J
J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
[TBL] [Abstract][Full Text] [Related]
15. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
Peller PJ; Ho VB; Kransdorf MJ
Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
[TBL] [Abstract][Full Text] [Related]
16. Diffuse hepatic and splenic uptake of Tc-99m methylene diphosphonate on bone scintigraphy after intravenous administration of gadolinium-containing MRI contrast.
Shi X; Jing H; Zhuang H; Zhang Y; Jin X; Li F
Clin Nucl Med; 2011 Mar; 36(3):178-82. PubMed ID: 21285673
[TBL] [Abstract][Full Text] [Related]
17. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of (99m)Tc-IgG scintigraphy in the diabetic foot and comparison with (99m)Tc-MDP scintigraphy.
Asli IN; Javadi H; Seddigh H; Mogharrabi M; Hooman A; Ansari M; Jalallat S; Assadi M
J Nucl Med Technol; 2011 Sep; 39(3):226-30. PubMed ID: 21795373
[TBL] [Abstract][Full Text] [Related]
19. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases.
Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D
Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851
[TBL] [Abstract][Full Text] [Related]
20. The value of quantitative uptake of (99m)Tc-MDP and (99m)Tc-HMPAO white blood cells in detecting osteomyelitis in violated peripheral bones.
Ballani NS; Al-Huda FA; Khan HA; Al-Mohannadi S; Mahmood H; Al-Enezi F
J Nucl Med Technol; 2007 Jun; 35(2):91-5. PubMed ID: 17496004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
